Laura Sepp-Lorenzino
2021
In 2021, Laura Sepp-Lorenzino earned a total compensation of $4.6M as Executive Vice President, Chief Scientific Officer at Intellia Therapeutics, a 171% increase compared to previous year.
Compensation breakdown
| Bonus | $259,308 |
|---|---|
| Option Awards | $3,066,731 |
| Salary | $441,000 |
| Stock Awards | $807,940 |
| Other | $4,770 |
| Total | $4,579,749 |
Sepp-Lorenzino received $3.1M in option awards, accounting for 67% of the total pay in 2021.
Sepp-Lorenzino also received $259.3K in bonus, $441K in salary, $807.9K in stock awards and $4.8K in other compensation.
Rankings
In 2021, Laura Sepp-Lorenzino's compensation ranked 2,885th out of 12,415 executives tracked by ExecPay. In other words, Sepp-Lorenzino earned more than 76.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,885 out of 12,415 | 77th |
Division Manufacturing | 1,148 out of 5,505 | 79th |
Major group Chemicals And Allied Products | 454 out of 2,375 | 81st |
Industry group Drugs | 398 out of 2,096 | 81st |
Industry In Vitro and In Vivo Diagnostic Substances | 7 out of 61 | 89th |
Source: SEC filing on May 2, 2022.
Sepp-Lorenzino's colleagues
We found four more compensation records of executives who worked with Laura Sepp-Lorenzino at Intellia Therapeutics in 2021.